Nilsen A, Hillestad T, Skingen V, Aarnes E, Fjeldbo C, Hompland T, et al. miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer. Mol Oncol. 2022;16:1402-1419 pubmed publisher

Kariya Y, Oyama M, Suzuki T, Kariya Y. αvβ3 Integrin induces partial EMT independent of TGF-β signaling. Commun Biol. 2021;4:490 pubmed publisher

Simpson K, Conquer van Heumen G, Watson K, Roth M, Martin C, Moorehead R. Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes. Cancer Cell Int. 2021;21:89 pubmed publisher

Lai H, Li J, Wang M, Huang H, Croce C, Sun H, et al. HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis. J Clin Invest. 2018;128:625-643 pubmed publisher

Sciacovelli M, Gonçalves E, Johnson T, Zecchini V, da Costa A, Gaude E, et al. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition. Nature. 2016;537:544-547 pubmed publisher

Zhang L, Zhang W, Li Y, Alvarez A, Li Z, Wang Y, et al. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Oncogene. 2016;35:5641-5652 pubmed publisher

Bhatt S, Gupta M, Khamaisi M, Martinez R, Gritsenko M, Wagner B, et al. Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes. Cell Metab. 2015;22:239-52 pubmed publisher

Gregory P, Bert A, Paterson E, Barry S, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593-601 pubmed publisher